Narrow Studies By:
—Disease/Health Benefits —
—Life Stage —
—Published Journal —
- Title [A-Z]
- Title [Z-A]
- Authors [A-Z]
- Authors [Z-A]
Plasma Phospholipid Long-Chain ω-3 Fatty Acids and Total and Cause-Specific Mortality in Older Adults: A Cohort StudyAuthors: D. Mozaffarian, et al. / Journal: Annals of Internal Medicine, April 2013
This is a 30-year study that looked at 2692 adults and compare mortality rates between those with higher plasma levels of omega-3 PUFA biomarkers with those who are lower. The study found those with higher omega-3 PUFA levels had a lower mortality rate than those who have less omega-3 PUFA levels. On average, those with higher levels lived 2.22 more years after age 65 years than those in the lowest quintile.
Inverse relationship between long-chain n-3 fatty acids and risk of sudden cardiac death in patients starting hemodialysisAuthors: A. N Friedman, et al. / Journal: Kidney International, February 2013
Experimental and clinical evidence suggests that long-chain n-3 fatty acids may protect against sudden cardiac death, the leading cause of mortality in hemodialysis patients. The study found significant inverse relationship was maintained even during the highest-risk first few months on hemodialysis. Thus, long-chain n-3 fatty acids are strongly and independently associated with a lower risk of sudden cardiac death in hemodialysis patients throughout the first year of hemodialysis.
Researchers studied over 1,500 late middle aged adults without dementia to see how the levels of omega-3s in their blood are related to signs of future dementia. Adults with the lowest amount of the fish-based omega-3, DHA, in their blood had smaller brain volumes and poorer performance in tests of visual memory; abstract thinking; and planning, organization, and carrying out of tasks than adults with higher DHA levels.